WHO issues warning on counterfeit diabetes drugs worldwide

As of 2022, counterfeit diabetes medications have been circulating worldwide, a concern that the World Health Organisation, or WHO, has alerted people about.

In a statement, the health authority notably mentioned research conducted since October 2023 in Brazil, the United States, and Britain.

The medication in question is Ozempic, a prescription drug with the active component semaglutide that is also authorised for the treatment of type 2 diabetes in the European Union.

The fake medication has the same appearance as the original.

The pill is increasingly being prescribed for weight loss since it also reduces appetite.

However, the WHO stated that fake medications might not have the proper concentration of active components, which might cause diabetics’ blood sugar levels to spiral out of control.

It went on to say that there’s a chance they also include other potentially harmful active components.

According to NAN, the WHO urged medical professionals, chemists, government regulators, and the general population to exercise caution.

The WHO advised people to purchase prescription drugs only from pharmacies; they should not buy them online.

It is recommended that users verify that the insulin pens’ dosage scale is readable, the label appears right, and the packaging is free of typographical errors.

Please don’t forget to “Allow the notification” so you will be the first to get our gist when we publish it. 
Drop your comment in the section below, and don’t forget to share the post.